International Plasma and Fractionation Association (IPFA)

What International Plasma and Fractionation Association (IPFA) does

The International Plasma and Fractionation Association (IPFA) is a non-profit organization founded in 1991 and headquartered in Amsterdam, the Netherlands. Based on its name, IPFA functions as an industry association serving the global plasma fractionation sector — the biopharmaceutical industry segment that processes collected human blood plasma into therapeutic products such as immunoglobulins, coagulation factors, and albumin. The organization is structured as a lean association with 8 employees and operates from a dedicated web domain (ipfa.nl).

The substantive content of IPFA's public-facing material was not retrievable from the available source data: the website returned only a Cloudflare-style verification/loader page ("One moment, please...") with no visible content, membership information, programs, events, publications, or governance disclosures. Consequently, the input data does not document IPFA's specific product offerings, technical or educational programs, membership criteria, regional chapters, or standards activities. As a non-profit association, the likely revenue mechanics would be member dues, event/conference registrations, and possibly sponsorships or grants — but none of these mechanics is confirmed in the source.

Investor-relevant signals (funding rounds, leadership team, M&A, partnerships, customer base, geographic footprint, pricing) are entirely absent from the input data. The only firmographic facts available are name, legal form (non-profit), founding year (1991), employee count (8), headquarters (Amsterdam, Netherlands), and the web domain. Any deeper analytical claims about IPFA's competitive position, strategic agenda, or financial trajectory cannot be substantiated from the data provided.

Name

International Plasma and Fractionation Association (IPFA)

Website

https://ipfa.nl

Company type

Private

Headcount range

1–10 employees

Short description

International Plasma and Fractionation Association (IPFA) is a non-profit industry association founded in 1991 and headquartered in Amsterdam, Netherlands, serving organizations in the global plasma fractionation sector.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

IPFA is a non-profit international industry association serving organizations involved in the collection of human plasma and the manufacture of plasma-derived medicinal products. The association provides a forum for industry networking, knowledge exchange, and collaborative engagement among plasma fractionators, blood establishments, and related stakeholders through conferences, workshops, and working group activities.

Differentiator

Problem solved

Functional benefit

Products and services

• IPFA Industry Membership Membership-based participation in the association for organizations engaged in plasma collection, fractionation, and the production of plasma-derived medicinal products, including access to industry working groups, meetings, and member communications.
• IPFA Conferences and Workshops Industry conferences and workshops bringing together plasma fractionators, regulators, blood establishments, and clinicians to discuss scientific, technical, and regulatory developments in the plasma products field.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Others

• International Alliance for Biological Standardization (IABS): Not-for-profit organization focused on scientific and regulatory aspects of biological standardization, including blood and plasma products. Comparable as an adjacent standards-focused body serving plasma/biologics stakeholders.

Broad incumbents

• Association for the Advancement of Blood & Biotherapies (AABB): Established international association for blood banking, transfusion medicine, and cellular therapies. A larger incumbent that covers plasma collection and processing among a broader blood/biotherapies agenda.

Regional players

• European Blood Alliance (EBA): Alliance of European blood establishments covering plasma supply, fractionation, and transfusion. Regionally comparable to IPFA but with a broader blood-system remit.

Emerging players

• World Federation of Hemophilia (WFH): Global not-for-profit focused on bleeding disorders, with significant overlap to plasma fractionation via coagulation factor therapies. Comparable as a disease-area community touching IPFA's downstream therapy users.

Direct peers

• Plasma Protein Therapeutics Association (PPTA): Global trade association representing manufacturers of plasma-derived therapies and the source-plasma collection industry. Closest comparable to IPFA as it serves an overlapping member base in the plasma fractionation value chain.
• International Society of Blood Transfusion (ISBT): International scientific society covering blood transfusion, including plasma collection and component preparation. Adjacent but overlapping with IPFA's domain in plasma-related science and standards.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks3 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/international-plasma-fractionation-association-ipfa-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Plasma and Fractionation Association (IPFA)